IP Library Patent Application 14617652
Patent Application
App. No. 14/617,652

Systems And Methods For Isotopic Source External Beam Radiotherapy

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/617,652
Abstract

The subject matter described herein provides methods for developing an IMRT treatment plan for a radiotherapy system. In one aspect, the method can include providing initial treatment parameters. These parameters can include a number of isotopic beams, a transmission angle for each beam, a prescribed dose for a target, and dose volume histogram constraints. The method can further include determining an initial fluence map including one or more beamlets. The initial fluence map can specify a fluence value for each beamlet. The method can further include determining a delivery sequence for the fluence values in the initial fluence map. The delivery sequence can include one or more apertures formed by the leaves of a collimator. These apertures can have a specified size constrained to substantially less than a maximum size associated with the collimator, when the isotopic beam is near a critical structure. Related apparatus and systems are also described.

Claims (45)

1 - 20 . (canceled)

21 . A method comprising:

determining an initial fluence map including one or more beamlets, the initial fluence map specifying a fluence value for each of the one or more beamlets; and

determining a first delivery sequence for the fluence values in the initial fluence map, the first delivery sequence including one or more apertures formed by a first set of one or more leaves and a second set of one or more leaves in a collimator, the one or more apertures having a specified size constrained to substantially less than a maximum size associated with the collimator when a penumbra of an isotopic beam overlaps with a critical structure.

22 . The method of claim 21 , wherein the specified size is not constrained when there is no overlap between the penumbra of the isotopic beam and the critical structure.

23 . The method of claim 21 , further comprising:

providing one or more initial treatment parameters selected from a group consisting of a number of isotopic beams, isocenters for each isotopic beam, a prescribed dose for a target, a maximum dose for a critical structure, and one or more dose volume histogram constraints.

24 . The method of claim 21 , wherein the specified size is substantially 2 centimeters by 2 centimeters or less.

25 . The method of claim 21 , wherein the first delivery sequence further specifies a maximum number of apertures or prohibits interdigitation between the first set of one or more leaves and the second set of one or more leaves.

26 . The method of claim 21 further comprising:

beginning treatment based on the determined initial fluence map and the determined first delivery sequence.

27 . The method of claim 21 further comprising:

calculating one or more dose values based on the one or more apertures in the first delivery sequence using an a priori dose calculation method;

comparing the one or more calculated dose values with a prescribed dose for a target; and

determining a second delivery sequence if there is an error between the one or more calculated dose values and the prescribed dose.

28 . The method of claim 27 , wherein the a priori dose calculation method is selected from a group consisting of a Monte Carlo simulation and a discrete ordinates method.

29 . The method of claim 27 , further comprising:

beginning treatment using a final set of apertures if there is no error between the one or more calculated dose values and the prescribed dose.

30 . A system comprising:

a processor; and

a memory, wherein the processor and the memory are configured to perform operations comprising:

determining an initial fluence map including one or more beamlets, the initial fluence map specifying a fluence value for each of the one or more beamlets; and

determining a first delivery sequence for the fluence values in the initial fluence map, the first delivery sequence including one or more apertures formed by a first set of one or more leaves and a second set of one or more leaves in a collimator, the one or more apertures having a specified size constrained to substantially less than a maximum size associated with the collimator when a penumbra of an isotopic beam overlaps with a critical structure.

31 . The system of claim 30 , wherein the specified size is not constrained when there is no overlap between the penumbra of the isotopic beam and the critical structure.

32 . The system of claim 30 , wherein the first delivery sequence further specifies a maximum number of apertures or prohibits interdigitation between the first set of one or more leaves and the second set of one or more leaves.

33 . The system of claim 30 , the operations further comprising:

beginning treatment based on the determined initial fluence map and the determined first delivery sequence.

34 . The system of claim 30 , the operations further comprising:

calculating one or more dose values based on the one or more apertures in the first delivery sequence using an a priori dose calculation method;

comparing the one or more calculated dose values with a prescribed dose for a target; and

determining a second delivery sequence if there is an error between the one or more calculated dose values and the prescribed dose.

35 . The system of claim 34 , the operations further comprising:

beginning treatment using a final set of apertures if there is no error between the one or more calculated dose values and the prescribed dose.

36 . A non-transitory computer-readable medium containing instructions to configure a processor to perform operations comprising:

determining an initial fluence map including one or more beamlets, the initial fluence map specifying a fluence value for each of the one or more beamlets; and

determining a first delivery sequence for the fluence values in the initial fluence map, the first delivery sequence including one or more apertures formed by a first set of one or more leaves and a second set of one or more leaves in a collimator, the one or more apertures having a specified size constrained to substantially less than a maximum size associated with the collimator when a penumbra of an isotopic beam overlaps with a critical structure.

37 . The non-transitory computer-readable medium of claim 36 , wherein the specified size is not constrained when there is no overlap between the penumbra of the isotopic beam and the critical structure.

38 . The non-transitory computer-readable medium of claim 36 , wherein the first delivery sequence further specifies a maximum number of apertures or prohibits interdigitation between the first set of one or more leaves and the second set of one or more leaves.

39 . The non-transitory computer-readable medium of claim 36 , the operations further comprising:

beginning treatment based on the determined initial fluence map and the determined first delivery sequence.

40 . The non-transitory computer-readable medium of claim 36 , the operations further comprising:

calculating one or more dose values based on the one or more apertures in the first delivery sequence using an a priori dose calculation method;

comparing the one or more calculated dose values with a prescribed dose for a target;

determining a second delivery sequence if there is an error between the one or more calculated dose values and the prescribed dose; and

beginning treatment using a final set of apertures if there is no error between the one or more calculated dose values and the prescribed dose.

Assignments (4)
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS Recorded Dec 28, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CRG ISSUER 2015-1
To: VIEWRAY, INC.; VIEWRAY TECHNOLOGIES, INC. (F/K/A VIEWRAY INCORPORATED)
Reel/Frame 047990/0423 →
CHANGE OF NAME Recorded Jul 13, 2016
From: VIEWRAY INCORPORATED
To: VIEWRAY TECHNOLOGIES, INC.
Reel/Frame 039336/0688 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Jun 26, 2015
From: VIEWRAY INCORPORATED
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 036020/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2015
From: DEMPSEY, JAMES F.; KAWRYKOW, IWAN
To: VIEWRAY, INCORPORATED
Reel/Frame 034922/0758 →